These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Intranasal application of Epstein-Barr virus/lipoplex to abrogate eosinophillia in murine model of allergic rhinitis. Han DM; Zhou B; Wang T; Wang XD; Fan EZ Chin Med J (Engl); 2006 Jun; 119(12):991-7. PubMed ID: 16805982 [TBL] [Abstract][Full Text] [Related]
3. IL-16 variability and modulation by antiallergic drugs in a murine experimental allergic rhinitis model. Akiyama K; Karaki M; Kobayshi R; Dobashi H; Ishida T; Mori N Int Arch Allergy Immunol; 2009; 149(4):315-22. PubMed ID: 19295235 [TBL] [Abstract][Full Text] [Related]
4. Alleviation of murine allergic rhinitis by C19, a C-terminal peptide of chemokine-like factor 1 (CKLF1). Zheng Y; Guo C; Zhang Y; Qi H; Sun Q; Xu E; Zhang Y; Ma D; Wang Y Int Immunopharmacol; 2011 Dec; 11(12):2188-93. PubMed ID: 22001899 [TBL] [Abstract][Full Text] [Related]
5. Beneficial effects of chelidonic acid on a model of allergic rhinitis. Oh HA; Kim HM; Jeong HJ Int Immunopharmacol; 2011 Jan; 11(1):39-45. PubMed ID: 20974310 [TBL] [Abstract][Full Text] [Related]
6. Immunostimulatory sequence oligdeoxynucleotide/cholera toxin B conjugate: a novel allergen-independent intranasal vaccine for allergic rhinitis. Won TB; Quan SH; Kim DY; Rhee CS; Lee CH Ann Allergy Asthma Immunol; 2009 Apr; 102(4):314-22. PubMed ID: 19441603 [TBL] [Abstract][Full Text] [Related]
7. Effect of 5-aminosalicylate on allergic rhinitis model in mice. Kuyama S; Yamamoto A; Sugiyama M; Kakuta H; Sugimoto Y Int Immunopharmacol; 2010 Jun; 10(6):713-6. PubMed ID: 20304104 [TBL] [Abstract][Full Text] [Related]
9. The effects of peroxisome proliferator-activated receptor-gamma agonist on a murine model of experimental allergic rhinitis. Jeon EJ; Lee SK; Park YS; Kim DH; Yum JH; Park CS Otolaryngol Head Neck Surg; 2008 Jul; 139(1):124-30. PubMed ID: 18585574 [TBL] [Abstract][Full Text] [Related]
10. Comparison of the efficacy of KOB03, ketotifen, and montelukast in an experimental mouse model of allergic rhinitis. Jung HW; Jung JK; Park YK Int Immunopharmacol; 2013 Jun; 16(2):254-60. PubMed ID: 23643816 [TBL] [Abstract][Full Text] [Related]
11. Topical application versus intranasal instillation: a qualitative comparison of the effect of the route of sensitization on trimellitic anhydride-induced allergic rhinitis in A/J mice. Farraj AK; Harkema JR; Kaminski NE Toxicol Sci; 2006 Jul; 92(1):321-8. PubMed ID: 16611626 [TBL] [Abstract][Full Text] [Related]
12. In vivo intranasal anti-CD23 treatment inhibits allergic responses in a murine model of allergic rhinitis. Zhou M; Du D; Zhao K; Zheng C J Mol Histol; 2013 Jun; 44(3):327-38. PubMed ID: 23377922 [TBL] [Abstract][Full Text] [Related]
13. Establishment of an allergic rhinitis model in mice for the evaluation of nasal symptoms. Tsunematsu M; Yamaji T; Kozutsumi D; Murakami R; Kimura S; Kino K Life Sci; 2007 Mar; 80(15):1388-94. PubMed ID: 17300813 [TBL] [Abstract][Full Text] [Related]
14. Anti-IL-33 antibody has a therapeutic effect in a murine model of allergic rhinitis. Kim YH; Yang TY; Park CS; Ahn SH; Son BK; Kim JH; Lim DH; Jang TY Allergy; 2012 Feb; 67(2):183-90. PubMed ID: 22050307 [TBL] [Abstract][Full Text] [Related]
15. Distinct effects of imperatorin on allergic rhinitis: imperatorin inhibits caspase-1 activity in vivo and in vitro. Oh HA; Kim HM; Jeong HJ J Pharmacol Exp Ther; 2011 Oct; 339(1):72-81. PubMed ID: 21730010 [TBL] [Abstract][Full Text] [Related]
16. IL-13 is essential to the late-phase response in allergic rhinitis. Miyahara S; Miyahara N; Matsubara S; Takeda K; Koya T; Gelfand EW J Allergy Clin Immunol; 2006 Nov; 118(5):1110-6. PubMed ID: 17088137 [TBL] [Abstract][Full Text] [Related]
17. Effects of dexamethasone on the expression of transforming growth factor-beta in the mouse model of allergic rhinitis. Lee SS; Won TB; Kim JW; Rhee CS; Lee CH; Hong SC; Min YG Laryngoscope; 2007 Aug; 117(8):1323-8. PubMed ID: 17762268 [TBL] [Abstract][Full Text] [Related]
18. Suppression of the Th2 pathway by suplatast tosilate in patients with perennial nasal allergies. Furukido K; Takeno S; Ueda T; Hirakawa K; Yajin K Am J Rhinol; 2002; 16(6):329-36. PubMed ID: 12512908 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of nasal barrier dysfunction at acute- and late-phase reactions in a guinea pig model of allergic rhinitis. Elovsson S; Smailagic A; Erjefalt I; Zackrisson C; Eriksson C; Wang X Vascul Pharmacol; 2005 Oct; 43(4):267-76. PubMed ID: 16257271 [TBL] [Abstract][Full Text] [Related]
20. Signals through CD40 play a critical role in the pathophysiology of Schistosoma mansoni egg antigen--induced allergic rhinitis in mice. Hattori H; Okano M; Kariya S; Nishizaki K; Satoskar AR Am J Rhinol; 2006; 20(2):165-9. PubMed ID: 16686380 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]